DexCom, Inc. vs Tenet Healthcare Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: DexCom, Inc. is the larger of the two by market cap. Which is the better fit depends on your goals.
| DXCM | THC | |
|---|---|---|
Market Cap | $33.79B | $20.89B |
Sector | Health | Health |
52-Week High | $89.53 | $262.63 |
52-Week Low | $54.84 | $161.37 |
Enterprise Value | $33.24B | $31.97B |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →